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Proteins can be modified by multiple posttranslational modifications
(PTMs), creating a PTM code that controls the function of proteins in
space and time. Unraveling this complex PTM code is one of the great
challenges in molecular biology. Here, using mass spectrometry-based
assays, we focus on the most common PTMs—phosphorylation and
O-GlcNAcylation—and investigate how they affect each other. We
demonstrate two generic crosstalk mechanisms. First, we define a
frequently occurring, very specific and stringent phosphorylation/
O-GlcNAcylation interplay motif, (pSp/T)P(V/A/T)(gS/gT), whereby
phosphorylation strongly inhibits O-GlcNAcylation. Strikingly, this strin-
gent motif is substantially enriched in the human (phospho)proteome,
allowing us to predict hundreds of putative O-GlcNAc transferase
(OGT) substrates. A set of these we investigate further and show them
to be decent substrates of OGT, exhibiting a negative feedback loop
when phosphorylated at the P-3 site. Second, we demonstrate that
reciprocal crosstalk does not occur at PX(S/T)P sites, i.e., at sites phos-
phorylated by proline-directed kinases, which represent 40%of all sites
in the vertebrate phosphoproteomes.
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Proteins are posttranslationally modified, yet the frequency atwhich these modifications occur and how they regulate protein
function is largely unexplored. Over 450 different posttranslational
modifications (PTMs) exist, having roles in cell signaling, regula-
tion of gene expression, or protein–protein interactions (1). Many
proteins are modified by multiple PTMs. These PTMs can affect
each other in what is generally termed “PTM crosstalk,” which has
become an intense subject of current research (2, 3). Examples of
crosstalk entail the priming phosphorylation on a protein substrate
by a single kinase that enables other kinases to phosphorylate sites
in the neighborhood. One key example is the phosphorylation of
Tau by the Cdk5 that leads to Tau hyperphosphorylation by
GSK3β (4). Additionally, the interplay between ubiquitination and
phosphorylation in the regulation of the EGF-mediated ERK
signaling pathway represents a clear example of how two different
PTMs can affect each other (5).
Another biologically intriguing PTM crosstalk is that between
O-GlcNAcylation and phosphorylation, as these both target the
same Ser/Thr amino acids (3, 6, 7). O-GlcNAcylation, whereby a
β-N-acetylglucosamine (O-GlcNAc) is added to a protein by the
enzyme O-β-(N-acetyl) glucosamine transferase (OGT), regulates
proteins involved in cell division, metabolism, and cell signaling.
Like phosphorylation, O-GlcNAcylation is a dynamic modification.
Virtually every reported OGT substrate is also a phosphoprotein,
making them all potentially affected by crosstalk (8). Initially, re-
ciprocal interplay, whereby phosphorylation and O-GlcNAcylation
occur on the same Ser/Thr site, was suggested as a major crosstalk
mechanism (9). However, while reciprocal relationships between
phosphorylation and O-GlcNAcylation have been suggested on a
few proteins (10, 11), this “yin–yang” reciprocal model proved to be
oversimplified. For instance, crosstalk can also occur whereby the
O-GlcNAcylation/phosphorylation of a Ser/Thr residue is differ-
entially affected by a phosphorylated/O-GlcNAcylated residue in
close proximity. Experimental evidence for this crosstalk came
from studies in which cellular stimuli were shown to increase both
O-GlcNAcylation and phosphorylation levels simultaneously (6, 7).
Although, many studies have demonstrated that crosstalk occurs,
studies that identify and colocalize both the phosphorylation and
O-GlcNAcylation sites simultaneously on the same protein/peptide
are sporadic. Thus, doubt still exists as to whether on a specific
protein molecule O-GlcNAcylation directly affects phosphorylation
or vice versa. Work by Trinidad et al. (12) suggested that phos-
phorylation and O-GlcNAcylation occur randomly with respect to
each another and that negative crosstalk is likely not a common
phenomenon. From that work it can be hypothesized that
phosphorylation/O-GlcNAcylation crosstalk is not really widespread.
Here, we address this hypothesis, assuming that new and better tools
are needed to explore phosphorylation/O-GlcNAcylation crosstalk.
PTMs generically increase the mass of a substrate; therefore
MS-based methods are ideal to investigate PTMs. Here, we use
high-resolution MS to investigate the kinetics and substrate spec-
ificity of human OGT on an extensive library of substrate-
mimicking peptides, whereby we addressed how such reactions
are dependent on substrate sequence and phosphorylation state.
We show that phosphorylation at specific sites on OGT substrates
hampers O-GlcNAcylation, enabling us to define a phosphoryla-
tion/O-GlcNAcylation crosstalk motif based on kinetic data: (pST)
P(TVA)(gST). This motif is enriched in the human proteome,
strongly suggesting a positive evolutionary selection. Furthermore,
our analysis revealed the critical role of a Pro at P+1 in this con-
sensus motif in preventing O-GlcNAcylation, suggesting that re-
ciprocal crosstalk is blocked when phosphorylation has been
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enforced by a Pro-directed kinase. As these phosphorylation events
represent in frequency about 40% of all phosphorylation sites in
human cells, this finding represents a significant step forward in
predicting and evaluating PTM crosstalk.
Results
Phosphorylation at Specific Sites Hampers O-GlcNAcylation. In an
initial attempt to investigate whether phosphoproteins can be
O-GlcNAcylated, we enriched phosphopeptides from A549 cells
and O-GlcNAcylated them in vitro. As a positive control, we
added a casein kinase II (CK2) peptide, a known, good substrate
of OGT (13). The CK2 peptide became O-GlcNAcylated on only
the predicted Ser347 with 100% occupancy. Intriguingly, although
the majority of the phosphopeptides contained unoccupied Ser/
Thr residues, only one of the thousands of phosphopeptides on
which the phosphate and O-GlcNAc modifications could be
mapped was found to be O-GlcNAcylated; this peptide originated
from CRMP2 (SI Appendix, Fig. S1 and Table S1). Thus, we
speculated that the primed phosphorylation might substantially
hamper subsequent O-GlcNAcylation. To verify this, it is impor-
tant to establish whether the presence of an O-GlcNAc moiety
alters phosphopeptide enrichment. Thus, first a mixture of
O-GlcNAc–modified and free unphosphorylated peptides were
subjected to iron-immobilized metal ion affinity chromatography
(Fe-IMAC) enrichment, and their relative abundances were
compared before and in the flow through from the Fe-IMAC
purification. The ratios of O-GlcNAc:free peptides remained
constant, showing that O-GlcNAcylated peptides have no affinity
for the Fe-IMAC resin (SI Appendix, Fig. S2A). Next, a mixture of
O-GlcNAcylated and unmodified phosphopeptides was analyzed.
The ratio of the intensities of the eluted O-GlcNAcylated:free
phosphopeptides remained constant before and after elution
from the Fe-IMAC column, confirming that the presence of an
O-GlcNAc moiety on phosphopeptides does not affect their ability
to bind and elute during phosphopeptide enrichment (SI Appendix,
Fig. S2B). In additional support of our hypothesis, in vivo studies
have shown that, upon treatment with kinase activators or phos-
phatase inhibitors, the levels of O-GlcNAcylation within cells de-
crease (14, 15).
To further test our hypothesis, we synthesized two peptides
corresponding to the zinc finger protein 281 (ZNF281res885–895) and
CK2res343–365, respectively (SI Appendix, Table S2), as these earlier
have been implicated in phosphorylation and O-GlcNAcylation
crosstalk. Ser347 O-GlcNAcylation in CK2 was shown to be an-
tagonistic to Thr344 phosphorylation, preventing CK2 from bind-
ing to Pin1, a process involved in enhancing CK2 stability (16).
O-GlcNAcylation of ZNF281 at Ser891 also plays a key regulatory
role that has been suggested to be involved in embryonic stem cell
differentiation (17). Interestingly, phosphorylation on Thr888 in
ZNF281 has been identified in large-scale phosphoproteomic
datasets (18). However, whether direct interplay exists between
these PTMs still remains to be verified. Here, we directly probed
the effect of phosphorylation of Thr888 on ZNF281 on the rate of
O-GlcNAcylation. Fig. 1 shows the mass spectra and the resulting
O-GlcNAcylation kinetics of both the nonmodified and the phos-
phorylated ZNF281 peptide before and after incubation with
OGT. Interestingly, less than 5% of the phosphorylated ZNF281
peptide was O-GlcNAcylated after 8 h compared with 90% of
the free ZNF281 peptide (Fig. 1B), showing that phosphoryla-
tion at Thr888 hampers Ser891 O-GlcNAcylation. Hypotheti-
cally, this crosstalk observed could add an additional regulatory
role to ZNF281 in stem cell differentiation, in addition to the
previously suggested regulatory role of O-GlcNAcylation on
Ser891 (17). To decipher whether this observed crosstalk is a more
general phenomenon, an unmodified and phosphorylated CK2
peptide was also incubated with OGT, and the relative peptide
O-GlcNAcylation levels were monitored (Fig. 1C). Consistent
with work by Cole and coworkers (16), the rate of Ser347
O-GlcNAcylation was severely reduced by Thr344 phosphor-
ylation (Fig. 1C).
MS/MS analysis of the O-GlcNAcylated ZNF281- and CK2-
derived peptide sequences revealed in both cases a single
O-GlcNAcylation site (SI Appendix, Figs. S3 and S4). Interestingly,
these phosphorylation sites that decreased the O-GlcNAcylation
rate were located at P−3 with respect to the O-GlcNAcylation
sites. Thus, we concluded that phosphorylation specifically at
P−3 may reduce the rate of subsequent O-GlcNAcylation. To
confirm that crosstalk primarily occurs when phosphorylation is
present at P−3, a peptide from CRMP2 whose O-GlcNAcylation
acceptor site is well established (19), was synthesized so that resi-
dues upstream and downstream of the O-GlcNAcylation site were
either left unmodified or phosphorylated (SI Appendix, Table S2).
The locations of the phosphorylation sites were chosen based on
their previous detection in vivo (20). Interestingly, comparable
O-GlcNAcylation levels were observed on Ser517 for the un-
modified peptide and the peptide in which Ser522 had been phos-
phorylated (at P+5 relative to the O-GlcNAc site) (SI Appendix,
Figs. S5 and S6). This reveals that phosphorylation downstream
of the O-GlcNAcylation site does not substantially alter the rate of
O-GlcNAcylation for CRMP2. In contrast, the quadruply phos-
phorylated CRMP2 peptide (Thr509, Thr514, Ser518, and Ser522)
showed a dramatic decrease in O-GlcNAcylation kinetics with only
2% of this peptide being O-GlcNAcylated. Interestingly, these re-
sults on CRMP2 are in line with our aforementioned experiments,
in which a large phosphopeptide library derived fromA549 cells was
O-GlcNAcylated. In these experiments, CRMP2 peptides were
detected in which Thr509, Thr514, Ser518, and Ser522 were phos-
phorylated. However, upon O-GlcNAcylation of this phosphopep-
tide library, only one phosphopeptide became O-GlcNAcylated in
which the phosphorylation site was at P+5 (Ser522) with respect to
the O-GlcNAcylation site (Ser517) (SI Appendix, Fig. S1).
Since phosphorylation at P-3 seems to specifically con-
strain O-GlcNAcylation rates, we sought to investigate whether
O-GlcNAcylation may also hamper protein phosphorylation.
Therefore, we selected two in vitro O-GlcNAcylated peptide se-
quences (ZNF281res885–895 and CRMP2res507–525) and incubated
them with a relevant kinase (Fig. 2). In neurons, phosphorylation
Fig. 1. Phosphorylation at P−3 hampers O-GlcNAcylation. (A) MS of free
and phosphorylated ZNF281res885–895 upon incubation with OGT for 0 h (Top)
and 5 h (Bottom). (B) Rates of O-GlcNAcylation of ZNF281res885–895 with (red
trace) and without (blue trace) phosphorylation at P−3. (C) As in B but for
CK2res343–365. The Insets show the O-GlcNAc incorporated after 8 h.
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of CRMP2 occurs initially at Ser522 by Cdk5, which primes
CRMP2 for subsequent phosphorylation by GSK3β at Ser518 and
Thr514 (21). Thus, the O-GlcNAcylated CRMP2 peptide was first
incubated with Cdk5, followed by incubation with GSK3β. In-
terestingly, both the free and O-GlcNAcylated CRMP2 were
phosphorylated on Ser522 with similar rates by Cdk5 (Fig. 2A and
SI Appendix, Fig. S7); however, upon the addition of GSK3β, the
presence of the O-GlcNAc moiety hampered phosphorylation,
with only two phosphate groups incorporated on average com-
pared with three for the unmodified CRMP2 (Fig. 2B). The
O-GlcNAcylated ZNF281 peptide also hindered subsequent
phosphorylation in assays in which we used six different protein
kinases (Fig. 2C). Together, the data show that O-GlcNAcylation
hampers phosphorylation, thus demonstrating that reciprocal
crosstalk exists between O-GlcNAcylation and phosphorylation.
Phosphorylation/O-GlcNAcylation Crosstalk Sites Identified. Very few
data exist wherein O-GlcNAcylation and phosphorylation are
detected simultaneously on the same protein molecule. Thus, we
hypothesized that the phosphorylation/O-GlcNAcylation interplay
reported here could represent a generic regulatory mechanism.
We defined a stringent putative motif: (T/S)P(V/T/A)(S/T) (the
O-GlcNAc and phospho sites are highlighted in bold and italic,
respectively) (Fig. 3A). This motif is based on several sets of
reported data, namely the O-GlcNAcylation motif extracted from
the 26 best-known OGT substrates (22), the PX(S/T) O-GlcNAc
motif described for HLA class I-bound peptides (23), the protein
sequences O-GlcNAcylated in this study (SI Appendix, Table S2),
and the finding reported in this paper that phosphorylation at
P−3 hampers O-GlcNAcylation. Using bioinformatics analysis, we
found that these sequences of four amino acids not only are very
common in the human proteome (Fig. 3B) but also are signifi-
cantly overrepresented (more than two times the number of oc-
currences), hinting at a positive evolutionary selection for either
structural or functional reasons (Fig. 3B). Interestingly, more than
40% of these sequences have been deposited in the PhosphoSi-
tePlus database in which 5,968 protein sequences had one or
multiple Ser/Thr residues within the motif phosphorylated. Of all
these sequences, 1,286 had a phosphorylated Ser/Thr residue at
P−3. We next queried whether these 1,286 protein sequences might
not only be substrates of kinases and OGT but also might display
interplay in between phosphorylation and O-GlcNAcylation,
whereby phosphorylation at P−3 in this consensus sequence
should prevent O-GlcNAcylation. In support of our hypothesis, a
few of these protein sequences have already been reported to be
involved in phosphorylation/O-GlcNAcylation crosstalk [e.g., in the
eIF4 that plays a role in mRNA translation (24) and the paired
amphipathic helix protein Sin3a that acts cooperatively with OGT
to repress transcription (25, 26)].
To investigate whether crosstalk exists more widely for proteins
exhibiting the motif (T/S)P(V/T/A)(S/T) defined here, two criteria
must be satisfied. First, proteins containing these motifs must be
OGT substrates. Second, phosphorylation at P−3 must decrease
the extent of O-GlcNAcylation. Thus, nine substrate-mimicking
peptides from the predicted proteins (Table 1 and SI Appendix,
Table S3), none previouslyknown to be OGT substrates, were se-
lected and individually incubated with OGT. The nine protein
sequences were readily O-GlcNAcylated (Fig. 3C) with the
O-GlcNAcylation sites matching precisely those predicted (Table 1
and SI Appendix, Figs. S8–S16 and Table S3). Next, the same nine
Fig. 2. O-GlcNAcylation hampers phosphorylation on nearby Ser/Thr resi-
dues. (A) Normalized phosphate incorporation on the free (gray trace) and
O-GlcNAcylated (blue trace) CRMP2res507–525 upon incubation with cdk5p25
kinase, ATP, and Mg2+. (B) The number of phosphorylation sites on the free
(gray bar) and O-GlcNAcylated (blue bar) CRMP2 peptide (i.e., the phosphor-
ylation stoichiometry) upon further incubation of the cdk5-phosphorylated
CRMP2 peptides with the second kinase, GSK3β (t = 10 h). The error bars
represent the SD from the mean. (C) Phosphorylation status of ZNF281res885-–895
upon incubation with the kinases PKA, ERK1, ERK2, cdk1cyclinA2, GSK3β, and
cdk5p25. The normalized phosphate incorporation is shown for the free and
O-GlcNAcylated ZNF281 peptide.
Fig. 3. Predicting phosphorylation/O-GlcNAcylation crosstalk. (A) Motif for
crosstalk with phosphorylation on P−3 and O-GlcNAc on 0. (B) The frequency
of all four amino-acid combinations in the human proteome. The sequences
matching the predicted crosstalk motif are in red. (C) The number of occur-
rences of each sequence from the crosstalk motif (red bars) compared with the
number expected if this sequence were to occur at random (gray bars), taking
into account that some amino acids are more abundant in the human pro-
teome. The sequences that are also deposited in the PhosphoSitePlus data-
base, i.e., those containing phosphorylation residues within or immediately
surrounding the motif, are shown in orange. (D) O-GlcNAc incorporation after
24 h on nine bioinformatically predicted OGT substrates (Table 1) with and
without phosphorylation at P−3.














peptides were synthesized with a phosphorylated Ser/Thr at P−3
(Table 1 and SI Appendix, Table S3) and were again incubated with
OGT (Fig. 3C). In eight of the nine phosphopeptides, the
O-GlcNAcylation became fully blocked. Only for the centromere
protein V peptide was a minor amount of O-GlcNAcylation de-
tected, albeit substantially less compared with its unphosphorylated
peptide counterpart. Thus, since in all peptides analyzed, crosstalk
was observed, we propose that all proteins containing the sequence
motif (T/S)P(V/T/A)(S/T) could represent bona fide OGT substrates
and be regulated by phosphorylation/O-GlcNAcylation crosstalk.
Next we validated whether this crosstalk pertains in cellular sys-
tems. Using a specific O-GlcNAcase (OGA) inhibitor, GlcNAcstatin
G, we substantially up-regulated the O-GlcNAcylation levels in
human HeLa cells (SI Appendix, Fig. S17A) and queried whether
this affected the extent of phosphorylation on peptides (follow-
ing enrichment from HeLa cells using Fe-IMAC) harboring the
(T/S)P(V/T/A)(S/T) sequence motif (Fig. 3A). Considering that re-
ciprocal crosstalk exists between O-GlcNAcylation and phosphory-
lation (Fig. 2), our assumption was that if negative crosstalk occurs,
whereby phosphorylation is at P−3 with respect to a putative
O-GlcNAcylation site, the amount of phosphorylation will decrease.
In the HeLa cells treated with the OGA inhibitor, 10 phosphory-
lated peptides were detected that harbored the (T/S)P(V/T/A)(S/T)
sequence motif, all being down-regulated (SI Appendix, Fig. S17B),
providing evidence that this negative crosstalk holds true in vivo for
these substrates. Moreover, in vitro experiments showed nine of
these down-regulated phosphopeptides were indeed OGT substrates
(SI Appendix, Table S4). In addition, upon incubation of four of
these peptides with the kinases cdk5 or p38α, decreased phosphate
incorporation at P−3 was observed when compared with their
O-GlcNAcylated (at P+3 with respect to the phosphorylation site)
and unmodified counterparts (SI Appendix, Fig. S18).
Reciprocal Interplay Does Not Occur on Ser/Thr Sites Targeted by
Pro-Directed Kinases. Reciprocal phosphorylation/O-GlcNAcylation
on the same site has been hypothesized to occur on various
proteins; however, the frequency and biological relevance of this
phosphorylation/O-GlcNAcylation competition in vivo remains
unclear. Upon analysis of the 5,968 protein sequences containing
our O-GlcNAcylation motif, (S/T)P(VTA)(S/T), 890 contained a
phosphorylated Ser/Thr at the O-GlcNAc site followed by a Pro,
i.e., putative substrates of Pro-directed kinases. To decipher
whether reciprocal interplay occurs at Pro-directed kinase substrate
sites, eight peptides were synthesized mimicking these putative
substrates originating from phosphoproteins with diverse cellular
functions (Table 1 and SI Appendix, Table S3). We hypothesized
that if reciprocal interplay occurs at these sites, these protein se-
quences should also be good substrates of OGT, as they conform to
our high-fidelity OGT substrate motif. Surprisingly, although all
these eight peptides should undergo reciprocal interplay based on
the computational prediction software Ying-O-Yang (27), none of
them did, as no O-GlcNAcylation was observed (Table 1 and SI
Appendix, Fig. S19). Thus, the presence of a Pro at P+1 has a
dramatic obstructing effect on O-GlcNAcylation. To verify this
preventative role of Pro on O-GlcNAcylation, a substrate-
mimicking peptide from the PEST proteolytic signal-containing
nuclear protein that is known to be a good substrate of OGT
was synthesized. Two peptides were synthesized in which the nat-
urally occurring alanine residue at P+1 was intentionally sub-
stituted with Pro (Fig. 3). Fig. 3A shows mass spectra after
incubation with OGT for both the natural and Ala/Pro substitution.
In contrast to the authentic protein sequence in which 60% was
O-GlcNAc modified, no O-GlcNAcylation was observed when the
+1 amino acid was substituted to Pro (Fig. 3A). Next, we chose a
substrate-mimicking peptide in which the naturally occurring Pro
residing at P+1 prevented O-GlcNAcylation and mutated this Pro
to Ala (Fig. 4). No O-GlcNAcylation was observed with the natural
protein sequence; however, O-GlcNAcylation was readily observed
when the Pro was substituted for Ala. Electron transfer dissociation
(ETD)-MS/MS confirmed that the O-GlcNAcylation site matched
that predicted site, based on our strict O-GlcNAcylation motif
(Figs. 3A and 4B). Therefore, our results show a strict negative
preference for Pro at P+1 with respect to the O-GlcNAcylation
site. From these data we conclude that reciprocal phosphorylation/
O-GlcNAcylation interplay does not occur on sites targeted by






LSPATPTSEG Thr377,Ser380 Ser380 65.3
LSPApTPTSEG Thr377,Ser380 Ser380 4.0
LpSPATPTSEG Thr377,Ser380 Ser380 57.0
SPGSTPTTPTSSQA Thr437,Ser440 Ser440 55.0
SPGpSTPTTPTSSQA Thr437,Ser440 Ser440 45.2
SPGSpTPTTPTSSQA Thr437,Ser440 Ser440 50.7
SPGSTPTTPpTSSQA Thr437,Ser440 Ser440 0
RKPVTVSPTTPTSPTEG Thr508,Thr513, Ser516 Thr508 9.1
ZNF687, Nup214, and dynein 1 light chain intermediate peptides contain multiple Ser/Thr residues but harbor
only a single O-GlcNAc site.
Fig. 4. Pro at P+1 obstructs O-GlcNAcylation. (A) MS of the PEST proteolytic
signal-containing nuclear proteinres137–146 (Upper) and the same protein in which
Ala at P+1 is substituted to Pro (Lower), upon incubation with OGT for 24 h.
(B) Mass spectra of the DNA-binding protein RFX7res1023–1032 (Upper) and the
same peptide sequence in which Pro at P+1 is substituted to an Ala (Bottom),
upon incubation with OGT for 24 h. ETD-MS/MS confirmed the O-GlcNAc sites.
Blue squares and asterisks indicate O-GlcNAc-containing and contaminant peaks,
respectively. The percent O-GlcNAcylation detected is shown at right.
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Pro-directed kinases. This finding is of tremendous importance,
since Pro-directed kinases represent in frequency about 40% of
all human phosphorylation sites (28, 29).
Using the same phosphoproteomics readout described above in
the HeLa cells treated with the OGA inhibitor, we assumed that
phosphopeptides harboring the (T/S)P(V/T/A)(S/T)P motif should
not be affected. In the HeLa cells treated with the OGA inhibitor,
12 phosphopeptides containing the (S/T)P(V/A/T)(pS/pT)P motif
were detected, all displaying no difference in phosphopeptide
abundance (SI Appendix, Fig. S17C). Two of these detected
phosphopeptides, protein FAM122B and cytoplasmic dynein 1
light intermediate chain 1, matched those made synthetically,
(Tables 1 and 2 and SI Appendix, Table S3).
Thus, based on in vitro screens, both our hypotheses about
crosstalk in (T/S)P(V/T/A)(S/T) and (T/S)P(V/T/A)(S/T)P motifs,
seem to hold in human cells. Still further in vivo studies are re-
quired, as our assumptions are likely oversimplifying the genuine
in vivo situation. Indeed, it is possible that O-GlcNAcylation levels
could affect phosphorylation of these sites indirectly. In addition,
we have not taken into account more regulatory levels of PTM
crosstalk that occur in cells, such as the possible activation/
deactivation of kinases by O-GlcNAcylation (30, 31).
Pro Prevents Promiscuous O-GlcNAcylation. Ser/Thr-Pro–rich regions
occur in proteins with high frequency. Most of these proteins
are modified by a plethora of PTMs. Due to the broad specificity
of protein kinases, multiple Ser/Thr residues within protein se-
quences can become phosphorylated. In sharp contrast, OGT has
a much more restricted substrate sequence specificity (22); thus
O-GlcNAcylation typically occurs at only one or a few Ser/Thr
residues within these Ser/Thr-rich sequences. It has been suggested
that there is little OGT substrate bias toward a specific amino acid
at P+1 (22), in contrast to our finding that Pro at P+1 blocks
O-GlcNAcylation. We investigated, therefore, whether Pro could
act to guide OGT to specific Ser/Thr sites. Therefore, three Ser/
Thr-rich peptides from the proteins ZNF687, Nup214, and cyto-
plasmic dynein 1 light intermediate chain 1 were synthesized
(Table 2 and SI Appendix, Table S3). Interestingly, despite the fact
that these contained multiple predicted O-GlcNAcylation sites
(27), only one Ser/Thr on each peptide became O-GlcNAcylated
(Table 2). In all three cases, the O-GlcNAcylation motif was
PX(S/T) (the O-GlcNAc site is in bold, and “X” represents any
amino acid) (SI Appendix, Figs. S20–S22). No O-GlcNAcylation
occurred at the PX(S/T) motif when Pro was at P+1 with respect
to the O-GlcNAcylation site. Thus, OGT shows a strict negative
preference of Pro at P+1, preventing promiscuous O-GlcNAcylation
in Ser/Thr-Pro–rich regions of proteins.
The Nup214 and ZNF687 sequences selected contain multi-
ple reported phosphorylation sites in close proximity to the
O-GlcNAcylation site observed. Thus, in addition to Pro preventing
promiscuous O-GlcNAcylation, according to our phosphorylation/
O-GlcNAcylation consensus motif, phosphorylation at specific sites
may also prevent O-GlcNAcylation on these proteins. Therefore,
ZNF687res373–382 was synthesized, in which we phosphorylated
Ser374 and Thr377 (at P−6 and P−3, respectively, with respect to the
O-GlcNAc site), and the percentage O-GlcNAcylation on the
phosphopeptides was compared with that of the unmodified peptide
(Table 2). The phosphosites were chosen based on their reported
detection (32). Consistent with our previous data on CRMP2 (SI
Appendix, Fig. S6), phosphorylation at P−3 dramatically reduced the
rate of O-GlcNAcylation, whereas the P−6 phosphosite had little
effect (Table 2 and SI Appendix, Fig. S23). Next, we synthesized
peptides corresponding to Nup214res430–443 in which Ser433, Thr434,
and Thr439 were phosphorylated (at P−7, P−6, and P−1, re-
spectively, with respect to the O-GlcNAc site). Upon incubation
with OGT, phosphorylation at either the P−6 or the P−7 site had
no/very little effect on the O-GlcNAcylation rate, suggesting these
are not involved in phosphorylation/O-GlcNAcylation crosstalk
(Table 2 and SI Appendix, Fig. S24). In contrast, phosphorylation
at P−1 prevented O-GlcNAcylation suggesting that, in addition to
phosphorylation at P−3, phosphorylation at P−1 can also hamper
the O-GlcNAcylation rate of Nup214 (Table 2 and SI Appendix,
Fig. S24).
Data that underscore our finding that Pro at P+1 prevents pro-
miscuous O-GlcNAcylation come from experiments performed on
the microtubule-associated protein Tau (33). Based on prediction
software (34) and the best known O-GlcNAcylation motif (22),
O-GlcNAcylation is predicted to occur on Ser202, Thr205, and
Ser208 in Tau (sequence R194SGYSSPGSPGTPGSR209) [i.e., all
(S/T)PG(S/T) motifs; the O-GlcNAc site is highlighted in bold].
Table 2. Peptides used to identify crosstalk motif





RSTTPTSSPF* Thr2682 Ser2685 Yes
RDTPTSAGPN* Thr139 Ser142 Yes
EKTPVSGSLK* Thr1385 Ser1388 Yes
EKLTPTSKQL* Thr678 Ser681 Yes
IPMTPTSSFV* Thr392 Ser395 Yes
GPDTPVSADA* Thr289 Ser292 Yes
LPTPTSAPTP* Thr1191 Ser1192 Yes
TPATPTSSAS* Thr101 Ser104 Yes
PEPSTPVSGQ* Thr1226 Ser1229 Yes
RLTPVSPVQH† Ser1028 Ser1028 ND
QKTPTSPLSP† Ser1256 Ser1256 ND
SPRTPVSPVK† Thr444,Ser447 Ser447 ND
DFTPVSPAPSPTR† Ser115,Ser119 Ser115 ND
SRPSPGTPTSPSN† Ser479,Thr482, Thr484,Ser485, Ser487 Ser485 ND
KSTWTPTSPG† Ser684 Ser684 ND
LNPGTPVSPQ† Ser2203 Ser2203 ND
YSPTSPSYSPTSPS† x x ND
ND, no O-GlcNAcylation detected; x, two heptad repeats from RNA polymerase II; thus this 14mer peptide
represents any/all of these repeats.
*Proteins with (S/T)PX(S/T) motif for which evidence exists that the first S/T can be phosphorylated. The predicted
and observed O-GlcNAc sites are shown. The effect phosphorylation has on O-GlcNAcylation is shown in Fig. 3D.
†Proteins that additionally have a Pro at P+1.














However, consistent with our work, O-GlcNAcylation was observed
only on Ser208 (33), the only predicted O-GlcNAcylation site that
does not contain a Pro at P+1. Thus, in addition to ZNF687 and
Nup214, Pro can also guide OGT to specific sites on Tau, pre-
venting O-GlcNAcylation on Ser202/Thr205.
Discussion
Previously, two distinctive mechanisms for crosstalk have been
reported, namely one whereby O-GlcNAcylation is affected by the
presence of a phosphate moiety on nearby Ser/Thr sites (or vice
versa) and another whereby phosphorylation and O-GlcNAcylation
occur on the same Ser/Thr residues and thus are mutually exclusive,
known as “reciprocal interplay.” Here, we interrogate both these
scenarios, introducing a MS-based kinetic assay to systematically
monitor crosstalk, enabling rules for this PTM crosstalk to be defined.
To address the first mechanism, we show that in the most
optimal OGT substrate sequence motif (S/T)P(V/T/A)(S/T),
phosphorylation specifically at P−3 with respect to the O-GlcNAc
site hinders or even blocks O-GlcNAcylation (Figs. 1 and 5).
Phosphorylation on other sites, both up- and downstream of the
OGT site, has a much smaller or even a negligible inhibiting ef-
fect. This dramatic effect of phosphorylation on P−3 can be
partly explained upon examination of the OGT structure in which
the CK2 peptide GSTPVSSA occupies the active site [Protein
Data Bank (PDB) ID code 4GYY] (Fig. 5A). The P−3 residue is
located immediately above the UDP cofactor; thus a phosphate
at this position would cause steric hindrance, preventing the
peptide from fitting tightly into the OGT active site. In support of
this, native MS experiments on the TAB1 protein have shown
differing rates of O-GlcNAcylation of Ser391 compared with
Ser395, with the rate difference being attributed to the differing
residues at P−3 (35). Taken together, our data not only confirm
that O-GlcNAcylation is affected by the presence of a phosphate
moiety on nearby Ser/Thr sites but also pinpoint this effect pre-
cisely to phosphorylation at P−3, a significant insight.
Addressing the aforementioned reciprocal mechanism, our data
reveal that reciprocal crosstalk cannot occur when the phosphory-
lation is carried out by a Pro-directed kinase (Fig. 5B and SI Ap-
pendix, Fig. S18), or in other words when the residue affected is
followed by a Pro. Since in all vertebrates more than 40% of Ser/Thr
residues that are phosphorylated are followed by Pro at P+1 (28),
reciprocal phosphorylation/O-GlcNAcylation crosstalk, as sug-
gested previously (12), is much more restricted and less frequent
than initially proposed.
Finally, we provide insights into how OGT recognizes its
substrates. We show that O-GlcNAcylation on our defined motif
(S/T)P(V/T/A)(S/T) cannot occur when Pro is present at P+1 (Table
1 and SI Appendix, Fig. S1). Pro thus acts to guide OGT to specific
Ser/Thr sites, preventing promiscuous O-GlcNAcylation on proteins
containing Ser/Thr-Pro–rich sequences (Table 2 and SI Appendix,
Fig. S23). Pro could be unfavorable for two reasons. First, it could
prevent the hydrogen-bonding interactions needed for efficient
enzyme-substrate recognition. Second, the presence of two Pro res-
idues in the OGT substrate (at P−2 and P+1) could restrict its
flexibility that is needed for the protein sequence to thread through
the tetratrico peptide repeats (TPR) of OGT into its active site.
In summary, we define a very stringent crosstalk motif, (pSp/T)P
(V/A/T)(gS/gT)(X-P), whereby phosphorylation at P−3 inhibits
O-GlcNAcylation and “X-P” represents any amino acid except Pro.
Since our defined motif is present in the consensus sequences for
the kinases ERK1, ERK2, CKI, and GSK3β, this crosstalk likely
has specific functional relevance in the protein substrates of these
aforementioned protein kinases. All of the protein sequences
queried here that contained this motif in the unphosphorylated
form are in our assays good substrates of OGT, the modification of
which is prevented upon phosphorylation at P−3. Thus, we propose
that 1,048 protein sequences [1,286 total (pSp/T)P(V/A/T)(S/T)
sequences minus 238 (S/T)P(V/A/T)(S/T)P sequences] in the
PhosphoSitePlus database may undergo phosphorylation/
O-GlcNAcylation crosstalk. This may even underrepresent the
number of proteins that could undergo crosstalk at adjacent sites,
as other motifs, such as (S/T)PG(S/T) in the case of Tau (33), and
quite different sequences, such as res55-58 (LLPT) in the case of
c-myc (11), can also participate in phosphorylation/O-GlcNAcylation
crosstalk. In addition, a more global form of crosstalk also occurs
whereby the enzymes involved in the crosstalk reported herein
themselves contain PTMs that can alter their function (31, 36).
For example, OGT has been reported to be activated by tyrosine
phosphorylation (36), and CaMKII kinase has been reported to be
activated by O-GlcNAcylation (31). Finally, we hypothesize that
since the majority of O-GlcNAcylation substrates known to date
occur either on intrinsically disordered regions of proteins (37) or
cotranslationally before protein folding (38), the results described
here will have implications for intact protein substrates, modu-
lating their function in vivo.
Materials and Methods
O-GlcNAcylation Assays. His-hOGT16–1036 was expressed in Sf9 insect cells and
was purified using Ni affinity and size-exclusion chromatography. The synthetic
peptides OGT and UDP-GlcNAc were incubated at 37 °C, 300 rpm, pH 8 in
an Eppendorf Thermomixer. O-GlcNAcylation was quenched at various time
points by dilution into 10% formic acid (FA).
Phosphorylation Assays. Synthetic peptides, kinase,Mg, andATPwere incubated
at 30 °C, 300 rpm in an Eppendorf Thermomixer. Aliquots were taken over time
and quenched by the addition of an excess of EDTA and dilution into 10% FA.
Proteomics. A549 and HeLa cells were lysed, reduced and alkylated, and
digested with trypsin, and the resulting phosphopeptides were enriched using
Fe-IMAC. For the O-GlcNAcylation assays with the A549 phosphopeptides,
CK2res339–352 was added to the phosphopeptide library and subsequently in-
cubated with OGT with a 50-fold excess of UDP-GlcNAc at 37 °C, for 24 h. To
monitor crosstalk, the relative abundance of phosphopeptides enriched from
WT and HeLa cells treated with O-GlcNAcstatin G were compared using label-
free quantitation. Analysis was carried out on an Agilent 1290 UPLC system
coupled to an Orbitrap Fusion Tribrid mass spectrometer. For more experi-
mental details, see SI Appendix.
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Fig. 5. Crosstalk mechanisms. (A, Left) An optimal OGT substrate motif
predicts a Ser/Thr near the P0 O-GlcNAc site. Phosphorylation at P−3 ham-
pers O-GlcNAcylation. (Right) A structural basis for this observation can be
postulated, looking at the OGT active site (gray surface) with UDP (white
sticks) and the CK2 peptide substrate (green sticks) bound (PDB ID code
4GYY). CK2 residues are labeled with respect to the O-GlcNAcylation site.
The small pocket size at P−3 suggests that the incorporation of a phosphate
moiety here is sterically hindered. For clarity, the TPR domain on OGT is
omitted. (B) Reciprocal crosstalk between phosphorylation/O-GlcNAcylation
is not likely on Pro-directed phosphorylation sites.
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